105.45
Merit Medical Systems Inc stock is traded at $105.45, with a volume of 524.57K.
It is down -0.25% in the last 24 hours and up +3.34% over the past month.
See More
Previous Close:
$105.71
Open:
$105.36
24h Volume:
524.57K
Relative Volume:
0.95
Market Cap:
$6.00B
Revenue:
$1.33B
Net Income/Loss:
$120.04M
P/E Ratio:
51.44
EPS:
2.05
Net Cash Flow:
$172.71M
1W Performance:
+0.68%
1M Performance:
+3.34%
6M Performance:
+8.03%
1Y Performance:
+40.36%
Merit Medical Systems Inc Stock (MMSI) Company Profile
Name
Merit Medical Systems Inc
Sector
Industry
Phone
(801) 253-1600
Address
1600 WEST MERIT PARK WAY, SOUTH JORDAN, UT
Compare MMSI with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
MMSI
Merit Medical Systems Inc
|
105.45 | 6.00B | 1.33B | 120.04M | 172.71M | 2.05 |
![]()
ISRG
Intuitive Surgical Inc
|
496.36 | 177.83B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
226.04 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
92.70 | 45.85B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
222.30 | 32.66B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
BAX
Baxter International Inc
|
34.02 | 17.45B | 17.28B | 108.00M | 391.00M | 0.20 |
Merit Medical Systems Inc Stock (MMSI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-28-25 | Initiated | JP Morgan | Overweight |
Dec-11-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Jun-28-24 | Initiated | Robert W. Baird | Outperform |
Apr-11-24 | Initiated | CL King | Buy |
Feb-07-24 | Initiated | BofA Securities | Neutral |
Dec-21-23 | Upgrade | Canaccord Genuity | Hold → Buy |
Dec-20-22 | Downgrade | Canaccord Genuity | Buy → Hold |
Jan-05-21 | Upgrade | Needham | Hold → Buy |
Sep-28-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
Feb-25-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Feb-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
Dec-12-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
Sep-24-19 | Initiated | Oppenheimer | Outperform |
Sep-10-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
Jul-26-19 | Downgrade | Needham | Buy → Hold |
Jul-26-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
Oct-02-18 | Reiterated | Needham | Buy |
Aug-07-18 | Downgrade | BofA/Merrill | Buy → Underperform |
Jul-24-18 | Reiterated | Needham | Buy |
Jun-01-18 | Reiterated | Needham | Buy |
May-18-18 | Reiterated | SunTrust | Buy |
Apr-26-18 | Reiterated | Needham | Buy |
Apr-20-18 | Initiated | Needham | Buy |
Mar-01-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Aug-28-17 | Downgrade | Raymond James | Strong Buy → Outperform |
Jul-20-17 | Initiated | BofA/Merrill | Buy |
Jun-20-17 | Initiated | SunTrust | Buy |
Apr-05-17 | Initiated | Wells Fargo | Outperform |
View All
Merit Medical Systems Inc Stock (MMSI) Latest News
(MMSI) Investment Report - news.stocktradersdaily.com
Brachytherapy Market Is Expected to Generate USD 1.6 Billion - openPR.com
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now - TradingView
Vanguard Group Inc. Buys 63,314 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) - MarketBeat
Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)? - simplywall.st
JPMorgan starts Merit Medical with Overweight, $120 target By Investing.com - Investing.com Australia
This Merit Medical Systems Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Assessing Merit Medical Systems: Insights From 12 Financial Analysts - Benzinga
JPMorgan Initiates Merit Medical Systems at Overweight With $120 Price Target - MarketScreener
JPMorgan starts Merit Medical with Overweight, $120 target - Investing.com India
Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD - The Manila Times
Major Breakthrough: Merit Medical's GERD Solution Achieves 94% Success in New Guidelines - Stock Titan
Merit Medical Stock May Rise as WRAPSODY CIE Shows Strong Results - Zacks Investment Research
Merit Medical releases 12-month efficacy results of WRAPSODY WAVE trial - TipRanks
Advancements In Peripheral Support Catheters Driving The Market: Key Trend Transforming the Transradial Acc... - WhaTech
Merit Medical Announces 12-Month Efficacy Results For WRAPSODY CIE In Hemodialysis Patients - Nasdaq
Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) - The Manila Times
Merit Medical Systems Reports Promising Six-Month and Twelve-Month Results for WRAPSODY CIE in WAVE Trial - Nasdaq
Merit Medical's WRAPSODY Achieves 70% Success Rate vs 41% Standard Treatment - Stock Titan
Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch - Yahoo Finance
(MMSI) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Biopsy Devices Market Generated Opportunities, Future Scope - openPR
Prostatic Artery Embolization Market Is Booming Worldwide - openPR
Merit Medical Systems, Inc. Rings the Opening Bell - Nasdaq
Merit Medical Systems, Inc. Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership - The Manila Times
U.S. Uterine Fibroid Treatment Market Future Business - openPR
Major Trend In The Procedure Trays Global Market 2025-2034: Innovative Solutions For Patient Safety Merit M... - WhaTech
Gastrointestinal Stent Market Booms with 6.0% CAGR Growth | TOP - openPR
Merit Medical: A Success Story That Keeps Getting Better - Seeking Alpha
MMSI Announces Commencement of Patient Enrollment in PREEMIE Study - Yahoo Finance
Interventional Neuroradiology Market Expansion: From $1.9B - openPR
Charles Schwab Investment Management Inc. Boosts Holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) - Defense World
Operating Procedure Trays Market: Key Drivers and Market - openPR
Merit Medical enrols first subject in trial of Bloom Micro Occluder System - Yahoo Finance
First patient enrolled in Merit Medical occluder system study - Mass Device
First Patient Enrolled in Merit Medical's PREEMIE Study - The Manila Times
Merit Medical Begins Clinical Trial for Groundbreaking Premature Baby Heart Treatment - StockTitan
Merit Medical Systems, Inc. to Host Earnings Call - ACCESS Newswire
Insider Selling: Merit Medical Systems, Inc. (NASDAQ:MMSI) CEO Sells $3,252,895.20 in Stock - Defense World
Insider Selling: Merit Medical Systems, Inc. (NASDAQ:MMSI) Insider Sells $3,087,000.00 in Stock - Defense World
Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Purchased by Edgestream Partners L.P. - MarketBeat
Hedge Fund and Insider Trading News: Steven Cohen, Christer Gardell, Boaz Weinstein, Rokos Capital Management, Silver Point Capital, Starboard Value, Graham Capital Management, Triata Capital, Walker & Dunlop Inc (WD), Merit Medical Systems Inc (M - Insider Monkey
Insider Selling: FRED LAMPROPOULOS Unloads $3.56M Of Merit Medical Systems Stock - Benzinga
Strategic Sale: Brian G Lloyd Decides To Exercise Options Worth $1.37M At Merit Medical Systems - Benzinga
Merit Medical Systems CEO Fred Lampropoulos sells $3.56 million in stock - Investing.com Australia
Merit Medical Systems CEO Fred Lampropoulos sells $3.56 million in stock By Investing.com - Investing.com South Africa
Merit Medical Systems’ chief legal officer sells $3.09m in stock - Investing.com Australia
Insider Sell: Brian Lloyd Sells 30,000 Shares of Merit Medical S - GuruFocus.com
Merit Medical Systems CFO Raul Jr. sells shares worth $555,292 By Investing.com - Investing.com South Africa
Merit Medical Systems’ chief legal officer sells $3.09m in stock By Investing.com - Investing.com South Africa
Merit Medical Systems Inc Stock (MMSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):